Congestive Heart Failure Clinical Trial
Official title:
Destiny Trial: Effects of Mitral Valve Annuloplasty With the Geoform Ring on Left Ventricular Geometry and Function in Patients With Cardiomyopathy
The primary aim of this study is to assess the changes on the shape and function of the left ventricle in patients with severe mitral valve regurgitation due to congestive heart failure and cardiomyopathy who undergo mitral valve reconstruction with a Geoform ring. Three-dimensional echocardiogram will be used for precise evaluation of the shape and function of the ventricle.
Congestive heart failure is a leading cause of hospitalization and mortality with an
estimated 5 million people affected in the United States of America. Ischemic and idiopathic
(dilated) cardiomyopathies are the two most common etiologies. As the left ventricle fails,
changes in ventricular geometry and function occurs that leads to functional mitral
regurgitation. Mitral regurgitation is a complication of end stage cardiomyopathy that
adversely affects survival and patient's functional status. Mitral regurgitation in these
patients is not an intrinsic disease of the mitral valve but rather results from mitral
annular dilatation and ventricular dilatation.
Geoform mitral annuloplasty ring reduces the antero-posterior diameter of the mitral valve
and elevates the posterior mitral annulus. Although it has been very effective on
eliminating mitral regurgitation its effects on ventricular geometry have not been fully
elucidated. Evaluation of ventricular and mitral valve geometry and function and their
interactions has been difficult. The availability of three dimensional echocardiogram with
sophisticated finite volume analysis allows us to evaluate the changes in ventricular
geometry associated with the implantation of the Geoform ring. We have then designed this
study with the purpose of evaluating the changes in left ventricular geometry and function
resulting from mitral valve annuloplasty with the Geoform ring in patients with left
ventricular dysfunction and congestive heart failure.
The two primary endpoints of this study will be:
1. To assess the changes on left ventricular geometry and function as assessed by 3D
echocardiography in patients with cardiomyopathy and severe mitral regurgitation who
undergo mitral valve annuloplasty with a Geoform ring. This assessment will be done
preoperatively, at three months, at six months, at one year, and at two years after the
procedure.
2. To evaluate the effects on mitral valve annuloplasty with a Geoform ring on functional
status.
Secondary endpoints will be:
3. To evaluate the effect of mitral valve annuloplasty with a Geoform ring on mortality.
4. To evaluate its effects on hospitalization for congestive heart failure.
5. To evaluate the effect on the need of further interventions for congestive heart
failure (insertion of ventricular assist device, transplantation, cardiac
resynchronization therapy).
;
Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04115735 -
His Bundle Recording From Subclavian Vein
|
||
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Completed |
NCT05563701 -
Evaluation of the LVivo Image Quality Scoring (IQS)
|
||
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT04037436 -
Functional Exercise and Nutrition Education Program for Older Adults
|
N/A | |
Recruiting |
NCT04703842 -
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
|
Phase 1/Phase 2 | |
Terminated |
NCT05594940 -
Heart Failure Monitoring With a Portable Ultrasound Device With Artificial Intelligence Assisted Tools: A Multi-Phase Observational Feasibility Study
|
||
Recruiting |
NCT04982081 -
Treating Congestive HF With hiPSC-CMs Through Endocardial Injection
|
Phase 1 | |
Completed |
NCT04394754 -
Evaluating Efficacy of Digital Health Technology in the Treatment of Congestive Heart Failure
|
N/A | |
Active, not recruiting |
NCT01385176 -
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
|
N/A | |
Not yet recruiting |
NCT05516290 -
Evaluating Clinical Trial Experiences of Individuals With Congestive Heart Failure
|
||
Terminated |
NCT02788656 -
Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril/Valsartan)
|
Phase 4 | |
Completed |
NCT02885636 -
Inhaled Beta-adrenergic Agonists to Treat Pulmonary Vascular Disease in Heart Failure With Preserved EF (BEAT HFpEF): A Randomized Controlled Trial
|
Phase 3 | |
Completed |
NCT02252757 -
Assess Measurements of Wireless Cardiac Output Device
|
N/A | |
Terminated |
NCT02205411 -
Clinical Trial to Evaluate the the ReliantHeart HeartAssist 5® VAD System in Patients Awaiting Heart Transplantation
|
N/A | |
Completed |
NCT01362855 -
Advance Care Planning Evaluation in Hospitalized Elderly Patients
|
||
Withdrawn |
NCT00346177 -
Stem Cell Study for Patients With Heart Failure
|
Phase 2 | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Active, not recruiting |
NCT01058837 -
SCD-HeFT 10 Year Follow-up
|
N/A | |
Completed |
NCT00957541 -
Evaluation of a Diagnostic Feature in a Cardiac Resynchronization Therapy (CRT) Device
|
Phase 2 |